Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,469,110
-$2,658,648 QoQ
Shares Held
177,674
-45.5% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#54
of 328 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. HRMY ranks #33 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,089,376 | $81,136,724 | |
| 2 | INSM |
INSMED Inc
|
689,981 | $73,565,774 | |
| 3 | EXEL |
Exelixis, Inc.
|
929,242 | $50,560,057 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
84,634 | $45,444,226 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
178,491 | $43,689,242 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
498,655 | $40,645,369 | |
| 7 | ABVX |
Abivax S.A.
|
270,612 | $36,061,755 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
622,603 | $34,205,808 |
All Filings in HRMY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,469,110 | 177,674 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $9,127,758 | 325,875 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $5,802,906 | 155,075 | Shares | Defined | 2026-02-12 | |
| 2025-03-31 | $3,274,824 | 98,669 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,162,640 | 54,066 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $958,802 | 31,780 | Shares | Defined | 2024-08-12 | |
| 2023-03-31 | $271,288 | 8,309 | Shares | Defined | 2023-05-12 | |
| 2020-12-31 | $1,222,303 | 33,812 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||